PE20011318A1 - SUBSTITUTE PHENYL COMPOUNDS, PHARNESILTRANSFERASE INHIBITORS - Google Patents

SUBSTITUTE PHENYL COMPOUNDS, PHARNESILTRANSFERASE INHIBITORS

Info

Publication number
PE20011318A1
PE20011318A1 PE2001000384A PE2001000384A PE20011318A1 PE 20011318 A1 PE20011318 A1 PE 20011318A1 PE 2001000384 A PE2001000384 A PE 2001000384A PE 2001000384 A PE2001000384 A PE 2001000384A PE 20011318 A1 PE20011318 A1 PE 20011318A1
Authority
PE
Peru
Prior art keywords
methyl
alkylene
cycloalkyl
alkyl
inhibitors
Prior art date
Application number
PE2001000384A
Other languages
Spanish (es)
Inventor
W Hutchins Charles
T Wang Gary
M Sullivan Gerard
L Sham Hing
A Hasvold Lisa
Taka Jennings Nelson Lissa
Wang Xilu
Lin Nan-Horng
Li Qun
A Fakhoury Stephen
J O Connor Stephen
L Gwaltney Ii Stephen
Wang Wei-Bo
L Curtin Michael
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PE20011318A1 publication Critical patent/PE20011318A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS FENILO SUSTITUIDOS DE FORMULA I DONDE A1 ES L1-M1-L2, ALQUILENO, DONDE EL ALQUILENO PUEDE ESTAR SUSTITUIDOS CON OH, OXO, Q1-Q2-R3, CON LA CONDICION QUE CUANDO A1 ES METILENO, EL METILENO ESTA SUSTITUIDO; L1 Y L2 SON ALQUILENO CON ALQUILO, CICLOALQUILO, CICLOALQUILALQUILO, ENTRE OTROS; M1 ES O, N(R4), N(R5)SO2, SO2N(R5), N(R5)C(O), ENTRE OTROS; Q1 ES O, N(R4), N(R5)C(O), N(R5)SO2, ENTRE OTROS; Q2 ES ALQUILENO, ALQUENILENO, ALQUINILENO; R1 ES HALO, CICLOALQUILO, ARILO, HETEROARILO; R2 ES HETEROARILO TAL COMO IMIDAZOLILO, PIRAZOLILO, PIRROLILO, ENTRE OTROS; R3 ES ALQUILO, CICLOALQUILO, ARILO, ENTRE OTROS; R4 ES H, ALQUILO, ALQUENILO, ALQUINILO, ALCANOILO, ENTRE OTROS; R5 ES H, ALQUILO, ARILO, ARILALQUILO, CICLOALQUILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS CLORHIDRATO DE 5-(BENCILOXI)(6-FLUORO-2'METIL(1,1'-BIFENIL)-3-IL)METIL)-1-METIL-1H-IMIDAZOL,CLORHIDRATO DE 2'-METIL(1,1'-BIFENIL)-3-IL)(-1-METIL-1H-IMIDAZOL-5-IL)METILETER BENCILICO,CLORHIDRATO DE 5-(BENCILOXI)(6-CLORO-2'METIL(1,1'-BIFENIL)-3-IL)METIL)-1-METIL-1H-IMIDAZOL, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION Y A COMPOSICIONES FARMACEUTICAS. LOS COMPUESTOS FENILO SUSTITUIDOS SON INHIBIDORES DE LA FARNESIL TRANSFERASA UTILES PARA EL TRATAMIENTO DE CANCERREFERS TO SUBSTITUTED PHENYL COMPOUNDS OF FORMULA I WHERE A1 IS L1-M1-L2, ALKYLENE, WHERE THE ALKYLENE MAY BE SUBSTITUTED WITH OH, OXO, Q1-Q2-R3, WITH THE CONDITION THAT WHEN A1 IS METHYLENE, METHYLENE IS SUBSTITUTED ; L1 AND L2 ARE ALKYLENE WITH ALKYL, CYCLOALKYL, CYCLOALKYLALKYL, AMONG OTHERS; M1 IS O, N (R4), N (R5) SO2, SO2N (R5), N (R5) C (O), AMONG OTHERS; Q1 IS O, N (R4), N (R5) C (O), N (R5) SO2, AMONG OTHERS; Q2 IS ALKYLENE, ALKENYLENE, ALKYLENE; R1 IS HALO, CYCLOALKYL, ARYL, HETEROARYL; R2 IS HETEROARYL SUCH AS IMIDAZOLIL, PYRAZOLIL, PYRROLYL, AMONG OTHERS; R3 IS ALKYL, CYCLOALKYL, ARYL, AMONG OTHERS; R4 IS H, ALKYL, ALKENYL, ALKINYL, ALCANOYL, AMONG OTHERS; R5 IS H, ALKYL, ARYL, ARYLALKYL, CYCLOALKYL, AMONG OTHERS. PREFERRED COMPOUNDS 5- (BENZYLOXY) (6-FLUORO-2'-METHYL (1,1'-BIPHENYL) -3-IL) METHYL) -1-METHYL-1H-IMIDAZOLE HYDROCHLORIDE, 2'-METHYL HYDROCHLORIDE (1 , 1'-BIPHENYL) -3-IL) (- 1-METHYL-1H-IMIDAZOL-5-IL) BENZYL METHYLETER, 5- (BENZYLOXY) (6-CHLORO-2'-METHYL (1,1'-BIPHENYL) HYDROCHLORIDE ) -3-IL) METHYL) -1-METHYL-1H-IMIDAZOLE, AMONG OTHERS. IT ALSO REFERS TO A PROCEDURE FOR THE PREPARATION AND TO PHARMACEUTICAL COMPOSITIONS. THE SUBSTITUTED PHENYL COMPOUNDS ARE INHIBITORS OF FARNESIL TRANSFERASE USEFUL FOR THE TREATMENT OF CANCER

PE2001000384A 2000-04-27 2001-04-27 SUBSTITUTE PHENYL COMPOUNDS, PHARNESILTRANSFERASE INHIBITORS PE20011318A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56325600A 2000-04-27 2000-04-27
US82220501A 2001-04-02 2001-04-02

Publications (1)

Publication Number Publication Date
PE20011318A1 true PE20011318A1 (en) 2002-01-08

Family

ID=27073227

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000384A PE20011318A1 (en) 2000-04-27 2001-04-27 SUBSTITUTE PHENYL COMPOUNDS, PHARNESILTRANSFERASE INHIBITORS

Country Status (8)

Country Link
EP (1) EP1276726A2 (en)
JP (1) JP2004509064A (en)
AU (1) AU2001259218A1 (en)
CA (1) CA2407093A1 (en)
HK (1) HK1053833A1 (en)
MX (1) MXPA02010608A (en)
PE (1) PE20011318A1 (en)
WO (1) WO2001081316A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
WO2003051880A1 (en) * 2001-12-19 2003-06-26 Janssen Pharmaceutica N.V. 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors
CN1717391A (en) 2002-10-21 2006-01-04 希龙公司 Inhibitors of glycogen synthase kinase 3
JP4681548B2 (en) 2003-07-22 2011-05-11 アステックス・セラピューティクス・リミテッド 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase (CDK) and glycogen synthetase kinase-3 (GSK-3) modulators
AU2005230846A1 (en) 2004-03-31 2005-10-20 Lexicon Pharmaceuticals, Inc. 2-aminomethylthiazole-5-carboxamides as protein kinase modulators
US7309709B2 (en) * 2004-04-01 2007-12-18 Pfizer Inc. Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders
AR054425A1 (en) 2005-01-21 2007-06-27 Astex Therapeutics Ltd PIPERIDIN ADDITION SALTS 4-IL-ACID AMID 4- (2,6-DICLORO-BENZOILAMINO) 1H-PIRAZOL-3-CARBOXILICO.
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
TW200806284A (en) * 2006-03-31 2008-02-01 Alcon Mfg Ltd Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
US8084614B2 (en) 2007-04-06 2011-12-27 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
AU2012272898A1 (en) 2011-06-24 2013-04-11 Amgen Inc. TRPM8 antagonists and their use in treatments
US8710043B2 (en) 2011-06-24 2014-04-29 Amgen Inc. TRPM8 antagonists and their use in treatments
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
US11299467B2 (en) 2017-07-21 2022-04-12 Antabio Sas Chemical compounds
CA3102645A1 (en) * 2018-06-07 2019-12-12 Disarm Therapeutics, Inc. Inhibitors of sarm1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8961382A (en) * 1981-11-06 1983-05-12 Imperial Chemical Industries Plc Amide derivatives
JP2868883B2 (en) * 1990-10-15 1999-03-10 株式会社トクヤマ Dioxolane derivative
US5733666A (en) * 1995-08-23 1998-03-31 Wayne Pigment Corp. Aqueous sealer composition for wood surfaces and process
US6297239B1 (en) * 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
WO2000001382A1 (en) * 1998-07-02 2000-01-13 Merck & Co., Inc. Inhibitors of prenyl-protein transferase

Also Published As

Publication number Publication date
EP1276726A2 (en) 2003-01-22
AU2001259218A1 (en) 2001-11-07
HK1053833A1 (en) 2003-11-07
MXPA02010608A (en) 2003-05-14
WO2001081316A3 (en) 2002-05-23
WO2001081316A2 (en) 2001-11-01
JP2004509064A (en) 2004-03-25
CA2407093A1 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
PE20011318A1 (en) SUBSTITUTE PHENYL COMPOUNDS, PHARNESILTRANSFERASE INHIBITORS
AR029216A1 (en) NON-PEPTIDIC INHIBITING COMPOUNDS OF THE VLA-4 DEPENDENT CELL UNION IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES; PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE
LV12618A (en) Use of sulphamate derivatives as steroid sulphatase inhibitors
AR015649A1 (en) INHIBITORS OF PROTEIC ISOPRENYL-TRANSFERS, COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
ID29452A (en) 4-OKSO-1,4-DIHYDRO-3-QUINOLINKARBOXAMIDE AS ANTIVIRUS AGENTS
IT1283588B1 (en) SYNERGIC MIXTURE OF STABILIZING AGENTS
SV1998000008A (en) SULFAMIDE-METALOPROTEASE INHIBITORS. REF. RAN 4070 \ 114
AR011116A1 (en) N-HYDROXY-BETA-SULFONIL PROPIONAMIDE DERIVED COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING IT
ES2116289T3 (en) N, N'-DIHALOIMIDAZOLIDIN-4-ONAS.
GEP19981299B (en) Method of Preparing Taxane Derivatives
PE20021089A1 (en) TRIAZOLE COMPOUNDS AS CYTOKINE INHIBITORS
PT96324A (en) METHOD FOR THE PREPARATION OF PEPTIDICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PA8495101A1 (en) DERIVATIVES OF 13-METHYLERITROMYCIN
CO5231142A1 (en) TIADIAZOLA AS AN ACTIVE INGREDIENT, IN COMBINATION WITH AT LEAST A SELECTED FUNGICIDE OF THE COMPONENTS THAT HAVE A FUNGICIATED ACTIVITY AGAINST PLANT DISEASES AND A METHOD FOR THE USE OF THE SAME
PE20040680A1 (en) NOVEL KINASE INHIBITORS
NO991494D0 (en) <beta> -sulfonylhydroxamic acids as matrix metalloproteinase inhibitors
DK1200426T3 (en) Substituted thien-3-yl-sulfonylamino (thio) carbonyl-thiazoline (thi) ones
ES2192031T3 (en) NEW AROMATIC AMIDAS, ITS PREPARATION PROCEDURE AND ITS APPLICATION AS MEDICATIONS.
BR9712424A (en) Deneurotrophin antagonist pharmaceutical composition
AR029145A1 (en) COMPOSITE OF REPLACED PIRROLIDINE HYDROXAMATE, METALOPROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND USE TO PREPARE A PHARMACEUTICAL COMPOSITION
DE69227627D1 (en) Alifatic propargylamines as selective MAO-B inhibitors and as neuroprotective agents
EA200300523A1 (en) TRIPEPTIDYL PEPTIDASE INHIBITORS
CO5050264A1 (en) DERIVATIVES OF 6-AZAURACILO AS IL-5 INHIBITORS PROCEDURES FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUCH DERIVATIVES
AR053560A1 (en) ANTIBACTERIAL COMPOUNDS OF 3,3 'DIALCOXI-2,2' -DIHIDROXI -1,1 '-BIFENILO 5,5' DISUSTITUTED AND RELATED METHODS
EA200000948A1 (en) NEW POLYCYCLIC AZAINDOLS, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
FA Abandonment or withdrawal